Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Genetics

Background:

• Cardiovascular disease remains the leading cause of death in the US, with limited survival improvements despite new therapeutics.
• Understanding novel molecular mechanisms, like non-coding RNAs, is crucial for advancing cardiovascular medicine.
• Long non-coding RNAs (lncRNAs) are increasingly recognized for their regulatory roles in gene expression.

Purpose of the Study:

• To review recent discoveries linking lncRNAs to cardiovascular diseases.
• To explore the molecular interactions of lncRNAs in cardiovascular pathogenesis.
• To assess the potential of circulating lncRNAs as biomarkers for heart disease diagnosis and prognosis.

Main Methods:

• Literature review of recent studies on lncRNAs and cardiovascular diseases.
• Analysis of molecular mechanisms involving lncRNAs in heart conditions.
• Evaluation of the diagnostic and prognostic utility of circulating lncRNAs.

Main Results:

• lncRNAs play critical roles in modulating the initiation and progression of cardiovascular diseases.
• Aberrant lncRNA expression is associated with the pathogenesis of conditions like ischemic heart failure.
• Circulating lncRNAs show potential as biomarkers for cardiovascular disease diagnosis and prognosis.

Conclusions:

• lncRNAs represent a promising area for novel therapeutic strategies in cardiovascular medicine.
• Further research into lncRNA functions and interactions is warranted for developing targeted treatments.
• Circulating lncRNAs hold significant potential for non-invasive diagnosis and prognosis of heart disease.